CSOFT International

25 Jan
CSOFT International Elevates Quality Standards: ISO Certifications Transferred to Boston Headquarters

Boston – January 24, 2024 – CSOFT International, a leading global provider of multilingual localization services, is pleased to announce a strategic move aimed at enhancing service quality and accessibility for North American and European clients. CSOFT has successfully transferred & renewed its ISO 17100, ISO 9001, and ISO 13485 certifications from Beijing to its Boston headquarters. ISO 17100, ISO 9001, and ISO 13485 are widely recognized in the localization and translation industry, reflecting a dedication to quality management systems, …

01 Jun
CSOFT to Host June Soiree, Exhibit at 2023 DIA Global in Boston

Boston – May 31, 2023 – CSOFT Health Sciences, leaders in clinical trial localization, are pleased to announce their return as exhibitors to DIA’s 2023 Annual Meeting, taking place June 25th – 29th at the Boston Conference and Exhibition Center in the Seaport neighborhood. With its attendance at booth #317, CSOFT reinforces its support for the worldwide drug development community and commitment to advancing patient diversity and centricity through language and technology as a global provider of medical translation in over 250 …

22 Sep
A Taste of Ginger Returns for Successful Gathering with CSOFT CEO Shunee Yee as Co-Chair, Bringing Focus to Patient Diversity in Diabetes Care

BOSTON – September 20, 2022 – PRWeb – CSOFT Health Sciences, leaders in medical translations, are pleased to announce a successful gathering for the 17th annual A Taste of Ginger on September 19th with CSOFT founder and CEO Shunee Yee as event Co-Chair, marking the event’s first return to in-person gathering following the pandemic. Hosted by Harvard University’s Joslin Diabetes Center and the Asian American Diabetes Initiative (AADI), A Taste of Ginger is a culinary fundraising event dedicated to addressing …

16 Jun
Veteran Biomedical R&D Executive Dr. Vladimir Misik Joins CSOFT Health Sciences as VP of Global Clinical Strategy in Time for DIA 2022

BOSTON, June 16, 2022 /PRNewswire/ — CSOFT Health Sciences, leader in medical translations, is pleased to announce its appointment of Dr. Vladimir Misik as Vice President of Global Clinical Strategy, expanding CSOFT’s senior advisory to its clinical trial localization and global regulatory consulting services. As a seasoned biomedical R&D executive and founder of multiple biomedical R&D ventures, Dr. Misik joins CSOFT in time for DIA’s first in-person Annual Meeting since the start of the pandemic, taking place June 19th to 23rd in Chicago. In addition to joining CSOFT’s …

24 May
CSOFT CEO Shunee Yee Appointed Chair of Joslin Diabetes Center’s A Taste of Ginger 2022

BOSTON – May 24, 2022 – CSOFT Health Sciences, leaders in medical translation and market access consulting, is pleased to announce CSOFT Founder and CEO Ms. Shunee Yee’s appointment as Chair to Harvard’s Joslin Diabetes Center’s 17th annual A Taste of Ginger event, marking her second year leading this major diabetes awareness educational and culinary fundraising event. Scheduled for September, this year’s A Taste of Ginger will be its first in person gathering since the start of the pandemic, with …

16 Mar
CSOFT Named Leader in Slator’s 2022 Language Service Provider Index

CSOFT International and CSOFT Health Sciences, leaders in cross-border communications and medical translations, have earned Slator’s 2022 Leader badge for end-to-end language services, raising CSOFT’s ranking over previous years as a perennial participant in Slator’s Language Service Provider Index (LSPI) report. With Slator’s Leader designation, CSOFT retains recognition for its standing in the tier of localization companies outside of the super agency sector with revenues greater than $25 million, reflecting strong year on year growth in key target markets including …

27 Jan
CSOFT’s Growth Continues with New ISO 17100 Certification

BOSTON, MA – CSOFT International, The Global Leader in Translation and Localization Solutions, has successfully attained its certificate for the International Translation Quality Certification, also known as ISO 17100:2015, for its global operations across North America, Asia, and Europe. “CSOFT has always made translation quality and customer satisfaction our top priorities,” said Shunee Yee, CSOFT President and CEO. “Achieving ISO 17100 certification validates CSOFT’s dedication to our quality management system, which ensures consistent and high-quality translations, improved customer satisfaction, and increased …

17 Nov
CSOFT Webinar: How to Successfully Conduct Overseas Clinical Trials as a Small-Medium Sized Biopharmaceutical Company

BOSTON, MA, November 17,2021. In this free webinar, our panelists Dr. Vladimir Misik and Joshua Maislin, will discuss current and future major clinical trial trends as well as important clinical trial strategy questions for small-medium Biopharmaceutical companies. In addition, the audience will be able to learn more about the importance of regulatory compliance and safety content translation as well as challenges and solutions for getting ready to enter foreign markets. Dr. Vladimir Misik, Partner & Founder at LongTaal, will outline …

23 Jun
DIA 2021: CSOFT Health Sciences Joins Global Push to Improve Diverse Patient Health Outcomes

BOSTON, June 22, 2021 /PRNewswire/ — CSOFT Health Sciences, leaders in medical translations, is excited to be exhibiting at the DIA 2021 Global Annual Meeting from June 28th – July 1st. With this year’s theme ‘Collaboration Without Boundaries’, the meeting brings together diverse groups from over 50 countries across healthcare, regulations, and science, and features prominent leaders in the life science sphere, including Merck Chairman and CEO Kenneth C. Frazier as keynote speaker. CSOFT will exhibit alongside pharmaceutical, biotech, and health technology industry leaders at the conference such as …

30 Apr
CSOFT CEO Shunee Yee Appointed Co-Chair of A Taste of Ginger for Joslin Diabetes Center

BOSTON, April 29, 2021 /PRNewswire/ — CSOFT Health Sciences, leaders in medical translation and market access consulting, announced today that CSOFT Founder and CEO Ms. Shunee Yee will serve as co-chair of A Taste of Ginger, an event hosted by Joslin Diabetes Center, the world’s leading diabetes care and research center. Shunee Yee’s appointment extends CSOFT Health Sciences’ support of multilingual communication solutions to promote patient diversity in advanced clinical trials and patient-centric care across the medical and pharmaceutical industry. As an independent, non-profit institution affiliated with Harvard …

Got questions?

Speak to one of our support agents.